Patent: 10,639,276
✉ Email this page to a colleague
Summary for Patent: 10,639,276
| Title: | Liposomes with ginsenoside as membrane material and preparations and use thereof |
| Abstract: | Among others, the present invention provides a blank liposome, preparation methods thereof, and a loaded liposome including the blank liposome and an active substance. The liposomes have a membrane comprising lipids and a ginsenoside of Formula I, and may further comprise a surfactant, a heat-sensitive excipient, a pH sensitive material, or an ion additive. ##STR00001## |
| Inventor(s): | Li; Chong (Shanghai, CN), Wang; Yahua (Shanghai, CN), Zhan; Huaxing (Shanghai, CN) |
| Assignee: | Shanghai Ginposome Pharmatech Co., Ltd. (Shanghai, CN) |
| Application Number: | 15/300,688 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,639,276
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Glaxosmithkline Biologicals | HAVRIX | hepatitis a vaccine | Injection | 103475 | February 22, 1995 | 10,639,276 | 2036-08-19 |
| Glaxosmithkline Biologicals | FLUARIX, FLUARIX QUADRIVALENT | influenza vaccine | Injection | 125127 | August 31, 2005 | 10,639,276 | 2036-08-19 |
| Glaxosmithkline Biologicals | FLUARIX, FLUARIX QUADRIVALENT | influenza vaccine | Injection | 125127 | December 14, 2012 | 10,639,276 | 2036-08-19 |
| Id Biomedical Corporation Of Quebec | FLULAVAL, FLULAVAL QUADRIVALENT | influenza vaccine | Injection | 125163 | October 05, 2006 | 10,639,276 | 2036-08-19 |
| Id Biomedical Corporation Of Quebec | FLULAVAL, FLULAVAL QUADRIVALENT | influenza vaccine | Injection | 125163 | November 10, 2009 | 10,639,276 | 2036-08-19 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
